We regret to report that long term Gallant Venture Ltd. (SGX:5IG) shareholders have had that experience, with the share price dropping 42% in three years, versus a market return of about 53%.

The first (FENhance 2) of two pivotal RMS studies met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses compared to teriflunomideIn a pivotal PPMS study ...